CVS Health Co. (NYSE:CVS) Shares Sold by Benjamin F. Edwards & Company Inc.

Benjamin F. Edwards & Company Inc. lowered its holdings in shares of CVS Health Co. (NYSE:CVS) by 10.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 58,891 shares of the pharmacy operator’s stock after selling 6,576 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in CVS Health were worth $3,478,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Ables Iannone Moore & Associates Inc. purchased a new position in shares of CVS Health during the fourth quarter worth about $32,000. Creekmur Asset Management LLC purchased a new position in shares of CVS Health in the 4th quarter valued at approximately $34,000. Steph & Co. raised its stake in shares of CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new stake in shares of CVS Health during the fourth quarter worth $36,000. Finally, Scarborough Advisors LLC purchased a new position in CVS Health in the 4th quarter valued at $37,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 1.5 %

Shares of CVS Health stock opened at $57.51 on Friday. The business has a 50 day moving average price of $58.31 and a 200 day moving average price of $62.52. The company has a market capitalization of $72.20 billion, a P/E ratio of 10.11, a P/E/G ratio of 0.79 and a beta of 0.53. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. During the same period in the prior year, the business earned $2.21 earnings per share. The business’s revenue was up 2.6% on a year-over-year basis. Sell-side analysts anticipate that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.63%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s payout ratio is 46.75%.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Monday, September 16th. Baird R W upgraded CVS Health to a “hold” rating in a research report on Thursday, May 30th. JPMorgan Chase & Co. cut their target price on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Finally, Wells Fargo & Company increased their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Eleven analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.